
Propanc Biopharma’s Joint Research Partnership with the Universities of Jaén and Granada Enters 13th Year
MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic […]
